negative effects of glp 1 agonists Safety and Tolerability Glucagon-Like Peptide-1 Receptor Agonists: A State-of-the-Art Narrative Review | Drugs GLP-1: Genetic Variants Related to

Version 1

doi:10.1021/jm070861j 21

While neither liraglutide nor semaglutide is FDA-approved for cardiovascular protection, research suggests both may help lower the risk of major heart-related events like heart attack, stroke, or cardiovascular death in people with type 2 diabetes

Intensified multifactorial intervention in type 2 diabetics with microalbuminuria leads to long-term renal benefits

doi: 10.1016/j.diabres.2015.07.015

Interestingly, research on clonal pancreatic -cells revealed that fatty acid load stimulated GIPR expression via the activation of PPAR- transcriptional factor under normoglycemia (99 mg/dL), but not during hyperglycemia (450 mg/dL) (59)